Keywords: ipsen, nine-month, sales, increase, french, drugmaker, says
Ipsen's nine-month sales increase 7%
Article | 10 November 2008
French drugmaker Ipsen says that consolidated group sales reached 735.1 million euros ($915.6 million ) for the first nine months of 2008, up 7.0% year-on-year. ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
